257 related articles for article (PubMed ID: 31678494)
1. S-Nitrosothiols as potential therapeutics to induce a mobilizable vascular store of nitric oxide to counteract endothelial dysfunction.
Perrin-Sarrado C; Zhou Y; Salgues V; Parent M; Giummelly P; Lartaud I; Gaucher C
Biochem Pharmacol; 2020 Mar; 173():113686. PubMed ID: 31678494
[TBL] [Abstract][Full Text] [Related]
2. The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione.
Sarr M; Sar FB; Gueye L; Kane MO; Wele A; Diallo AS; Schini-Kerth V; Muller B
Cardiovasc J Afr; 2011; 22(1):7-13. PubMed ID: 21298199
[TBL] [Abstract][Full Text] [Related]
3. S,S'-dinitrosobucillamine, a new nitric oxide donor, induces a better vasorelaxation than other S-nitrosothiols.
Dahboul F; Perrin-Sarrado C; Boudier A; Lartaud I; Schneider R; Leroy P
Eur J Pharmacol; 2014 May; 730():171-9. PubMed ID: 24625595
[TBL] [Abstract][Full Text] [Related]
4. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
[TBL] [Abstract][Full Text] [Related]
5. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between the observed stability and pharmacological properties of S-nitroso derivatives of glutathione and cysteine-related peptides.
Tullett JM; Rees DD; Shuker DE; Gescher A
Biochem Pharmacol; 2001 Nov; 62(9):1239-47. PubMed ID: 11705457
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
8. Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.
Seabra AB; Fitzpatrick A; Paul J; De Oliveira MG; Weller R
Br J Dermatol; 2004 Nov; 151(5):977-83. PubMed ID: 15541075
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in silico evaluation of a new nitric oxide donor, S,S'-dinitrosobucillamine.
Bouressam ML; Meyer B; Boudier A; Clarot I; Leroy P; Genoni A; Ruiz-Lopez M; Giummelly P; Liminana P; Salgues V; Kouach M; Perrin-Sarrado C; Lartaud I; Dupuis F
Nitric Oxide; 2017 Dec; 71():32-43. PubMed ID: 29051112
[TBL] [Abstract][Full Text] [Related]
10. Modulation of vascular responses of guinea-pig aorta by non-endothelial nitric oxide: A minor role for the endothelium.
Broadley KJ; Broadley HD
Vascul Pharmacol; 2019 Oct; 121():106580. PubMed ID: 31349085
[TBL] [Abstract][Full Text] [Related]
11. Augmented S-nitrosylation contributes to impaired relaxation in angiotensin II hypertensive mouse aorta: role of thioredoxin reductase.
Choi H; Allahdadi KJ; Tostes RC; Webb RC
J Hypertens; 2011 Dec; 29(12):2359-68. PubMed ID: 22025239
[TBL] [Abstract][Full Text] [Related]
12. The design of nitric oxide donor drugs: s-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP.
Kumari S; Sammut IA; Giles GI
Eur J Pharmacol; 2014 Aug; 737():168-76. PubMed ID: 24858367
[TBL] [Abstract][Full Text] [Related]
13. H(2)S and HS(-) donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells.
Ondrias K; Stasko A; Cacanyiova S; Sulova Z; Krizanova O; Kristek F; Malekova L; Knezl V; Breier A
Pflugers Arch; 2008 Nov; 457(2):271-9. PubMed ID: 18458940
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine and lactational exposure to fluoxetine enhances endothelial modulation of aortic contractile response in adult female rats.
Higashi CM; Sartoretto SM; Echem C; Lucchetti BFC; Carvalho MHC; Pelosi GG; Pinge-Filho P; Gerardin DCC; Moreira EG; Akamine EH; Ceravolo GS
Vascul Pharmacol; 2018 Sep; 108():67-73. PubMed ID: 29653281
[TBL] [Abstract][Full Text] [Related]
15. Chemerin influences endothelin- and serotonin-induced pulmonary artery vasoconstriction in rats.
Hanthazi A; Jespers P; Vegh G; Degroot GN; Springael JY; Lybaert P; Dewachter L; Mc Entee K
Life Sci; 2019 Aug; 231():116580. PubMed ID: 31216440
[TBL] [Abstract][Full Text] [Related]
16. Nitroso-sulfide coupled signaling triggers specific vasoactive effects in the intrarenal arteries of patients with arterial hypertension.
Cacanyiova S; Berenyiova A; Balis P; Kristek F; Grman M; Ondrias K; Breza J; Breza J
J Physiol Pharmacol; 2017 Aug; 68(4):527-538. PubMed ID: 29151069
[TBL] [Abstract][Full Text] [Related]
17. The presence of the endothelial layer reduces nitric oxide-induced hyporesponsiveness to phenylephrine in rat aorta.
Terluk M; Cunha Da Silva E; Antunes T; Assreuy J
Endothelium; 2004; 11(3-4):181-7. PubMed ID: 15370295
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta.
Chang KS; Stevens WC
Br J Pharmacol; 1992 Dec; 107(4):983-90. PubMed ID: 1467844
[TBL] [Abstract][Full Text] [Related]
19. S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular endothelial or smooth muscle cells.
Jaworski K; Kinard F; Goldstein D; Holvoet P; Trouet A; Schneider YJ; Remacle C
Eur J Pharmacol; 2001 Aug; 425(1):11-9. PubMed ID: 11672570
[TBL] [Abstract][Full Text] [Related]
20. Understanding the in-vivo relevance of S-nitrosothiols in insulin action.
Fernandes AB; Guarino MP; Macedo MP
Can J Physiol Pharmacol; 2012 Jul; 90(7):887-94. PubMed ID: 22694074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
